ATE62482T1 - Imidazolidindion-derivate. - Google Patents
Imidazolidindion-derivate.Info
- Publication number
- ATE62482T1 ATE62482T1 AT87310147T AT87310147T ATE62482T1 AT E62482 T1 ATE62482 T1 AT E62482T1 AT 87310147 T AT87310147 T AT 87310147T AT 87310147 T AT87310147 T AT 87310147T AT E62482 T1 ATE62482 T1 AT E62482T1
- Authority
- AT
- Austria
- Prior art keywords
- trifluoromethyl
- bromine
- chlorine
- fluorine
- alkyl
- Prior art date
Links
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical class O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 title 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 3
- 229910052794 bromium Inorganic materials 0.000 abstract 3
- 229910052801 chlorine Inorganic materials 0.000 abstract 3
- 239000000460 chlorine Chemical group 0.000 abstract 3
- 229910052731 fluorine Inorganic materials 0.000 abstract 3
- 239000011737 fluorine Chemical group 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 2
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 2
- -1 5-substituted imidazolidinedione Chemical class 0.000 abstract 1
- 208000002249 Diabetes Complications Diseases 0.000 abstract 1
- 206010012655 Diabetic complications Diseases 0.000 abstract 1
- 239000003288 aldose reductase inhibitor Substances 0.000 abstract 1
- 229940090865 aldose reductase inhibitors used in diabetes Drugs 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cosmetics (AREA)
- Indole Compounds (AREA)
- External Artificial Organs (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1986/002514 WO1993013092A1 (en) | 1986-11-24 | 1986-11-24 | Imidazolidinedione derivatives |
| EP87310147A EP0269355B1 (de) | 1986-11-24 | 1987-11-18 | Imidazolidindion-Derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE62482T1 true ATE62482T1 (de) | 1991-04-15 |
Family
ID=22195719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87310147T ATE62482T1 (de) | 1986-11-24 | 1987-11-18 | Imidazolidindion-derivate. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5011840A (de) |
| EP (1) | EP0269355B1 (de) |
| JP (1) | JPS63150278A (de) |
| AT (1) | ATE62482T1 (de) |
| DE (1) | DE3769286D1 (de) |
| DK (1) | DK614487A (de) |
| ES (1) | ES2031520T3 (de) |
| GR (1) | GR3001765T3 (de) |
| PT (1) | PT86183B (de) |
| WO (1) | WO1993013092A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3120857B2 (ja) * | 1990-02-19 | 2000-12-25 | 中外製薬株式会社 | 新規な縮合複素環化合物とこれを用いた抗喘息剤 |
| US5202318A (en) * | 1990-05-14 | 1993-04-13 | Syntex (U.S.A.) Inc. | Tricyclic compounds acting at serotonin receptor subtypes |
| US6555573B2 (en) * | 2000-12-21 | 2003-04-29 | The Quigley Corporation | Method and composition for the topical treatment of diabetic neuropathy |
| US7435725B2 (en) * | 2001-11-06 | 2008-10-14 | The Quigly Corporation | Oral compositions and methods for prevention, reduction and treatment of radiation injury |
| US20030105027A1 (en) * | 2001-11-06 | 2003-06-05 | Rosenbloom Richard A. | Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
| DE10210195B4 (de) | 2002-03-07 | 2005-12-15 | Schwarz Pharma Ag | Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz |
| US7083813B2 (en) * | 2002-11-06 | 2006-08-01 | The Quigley Corporation | Methods for the treatment of peripheral neural and vascular ailments |
| US20090018151A1 (en) * | 2007-02-23 | 2009-01-15 | Ezekiel Fink | Topical Treatment of Peripheral diabetic complications |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1342350A (en) * | 1969-12-30 | 1974-01-03 | Sumitomo Chemical Co | Naphthalimide derivatives |
| US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
| US4139532A (en) * | 1976-05-14 | 1979-02-13 | Basf Aktiengesellschaft | N-Acylaminonaphthalimides |
| IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
| US4209527A (en) * | 1979-05-16 | 1980-06-24 | Pfizer Inc. | Benzimidazolone derivatives |
| US4521416A (en) * | 1983-03-22 | 1985-06-04 | Warner-Lambert Company | 4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones and 6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones |
| AU568759B2 (en) * | 1984-07-17 | 1988-01-07 | Eli Lilly And Company | Pyridazinylimidazolinones |
| US4782064A (en) * | 1986-07-21 | 1988-11-01 | American Cyanamid Co. | 2-heteroaryl-alkyl-1H-benz[de]-isoquinoline-1,3(2H)-diones |
-
1986
- 1986-11-24 WO PCT/US1986/002514 patent/WO1993013092A1/en not_active Ceased
- 1986-11-24 US US07/435,529 patent/US5011840A/en not_active Expired - Lifetime
-
1987
- 1987-11-18 EP EP87310147A patent/EP0269355B1/de not_active Expired - Lifetime
- 1987-11-18 ES ES198787310147T patent/ES2031520T3/es not_active Expired - Lifetime
- 1987-11-18 AT AT87310147T patent/ATE62482T1/de not_active IP Right Cessation
- 1987-11-18 DE DE8787310147T patent/DE3769286D1/de not_active Expired - Lifetime
- 1987-11-20 PT PT86183A patent/PT86183B/pt not_active IP Right Cessation
- 1987-11-23 DK DK614487A patent/DK614487A/da not_active Application Discontinuation
- 1987-11-24 JP JP62295913A patent/JPS63150278A/ja active Pending
-
1991
- 1991-04-11 GR GR91400453T patent/GR3001765T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK614487A (da) | 1988-05-25 |
| JPS63150278A (ja) | 1988-06-22 |
| DE3769286D1 (de) | 1991-05-16 |
| EP0269355A1 (de) | 1988-06-01 |
| WO1993013092A1 (en) | 1993-07-08 |
| PT86183A (en) | 1987-12-01 |
| EP0269355B1 (de) | 1991-04-10 |
| PT86183B (pt) | 1990-11-07 |
| US5011840A (en) | 1991-04-30 |
| ES2031520T3 (es) | 1992-12-16 |
| DK614487D0 (da) | 1987-11-23 |
| GR3001765T3 (en) | 1992-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE144511T1 (de) | Tetrahydrobenzimidazol-derivate | |
| DE69709532D1 (de) | 1-Phenyl-Pyrazolderivate und ihr Verwendung als Schädlingsbekämpfungsmittel | |
| DK1022274T3 (da) | Mellemprodukter til fremstillingen af oxazolidindion og thiazolidindion derivater | |
| ES8505652A1 (es) | Procedimiento para preparar nuevas 1-bencil-aminoalquil-pirrolidinonas | |
| ATE62482T1 (de) | Imidazolidindion-derivate. | |
| YU12992A (sh) | 2-amino-1,2,3,4,-tetrahidronaftaleni supstituisani u prstenu | |
| ES549979A0 (es) | Procedimiento para preparar nuevas pirrolidina-2,5-dionas espiroenlazadas | |
| ATE172452T1 (de) | Bicyclische stichstoff enthaltende derivate als prolyl-endopeptidase inhibitoren | |
| EP1361225A4 (de) | Durch bicyclische aminogruppen substituierte verbindungen | |
| ATE71619T1 (de) | Pyridazinon-derivate. | |
| ATE446295T1 (de) | 2-amino-4-pyridylmethyl-thiazolinderivate und ihre verwendung als induzierbare no-synthase inhibitoren | |
| ATE504572T1 (de) | Derivate von aromatische heterocyclen enthaltende integraseinhibitoren | |
| ES2193168T3 (es) | Nuevos derivados de acido parabanico como inhibidores de aldosa reductasa. | |
| DE69526413D1 (de) | Heterocyclische Carboxyalkylderivate | |
| FI914219A0 (fi) | 3-(1h-indazol-3-yl)-4-pyridinaminer, foerfarande och mellanprodukter foer deras framstaellning och deras anvaendning som laekemedel. | |
| KR840007420A (ko) | 치환된 카복시-티아졸로[3,2-α] 피리미딘 유도체의 제조방법 | |
| ID26809A (id) | Senyawa-senyawa turunan sianoiminokuinoksalin | |
| DE3874982D1 (de) | Antipsychotische zusammensetzungen mit dioxopiperidin-derivaten. | |
| ATE259346T1 (de) | Benflumentolderivative und ihre verwendung gegen parasitäre protozoen und trematoden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |